EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of Single Fiber Transperineal Laser Ablation and Radiofrequency Ablation in the Treatment of Benign Prostatic Hyperplasia

Xiao Han, Peipei Yang, Xinyu Zhao, Ran Li, Jing Xiao, Hongliang Shen, Yan Zhang, Xian-Quan Shi

CardioVascular and Interventional Radiology · 2026

DOI: 10.1007/s00270-026-04490-8 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift CardioVascular and Interventional Radiology, 2026. Verfasst von Xiao Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, 95 Yongan Road, Beijing, 100050, China. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Laser Therapy, Catheter Ablation, Radiofrequency Ablation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: the Scientific Program of Tongzhou District, Beijing, The General Program of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To compare the efficacy, safety and operational efficiency of transperineal radiofrequency ablation (TPRFA) and single fiber transperineal laser ablation (TPLA) in patients with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: Patients with moderate to severe lower urinary tract symptoms were included and divided into TPRFA and TPLA groups. Changes in International Prostate Symptom Score (IPSS), quality of life (QoL), prostate volume (PV), post-void residual (PVR), and peak urine flow rate (Qmax) at 6 and 12 months were analyzed and compared between the two groups. Postoperative complications, operation time, ablation time were compared between the two groups. RESULTS: Thirty-six patients (20 TPRFA vs 16 TPLA) were analyzed. At 12 months, the between-group difference in change in IPSS, QoL, PV, Qmax and PVR from baseline was - 1.59 (95% CI: - 5.12 to 1.94, p = 0.37), 0.16 (95% CI: - 0.39 to 0.70, p = 0.57), - 5.00 (95% CI: - 10.41 to 0.41, p = 0.07), - 0.10 (95% CI: - 3.52 to 3.32, p = 0.95), - 6.40 (95% CI: - 93.30 to 81.09, p = 0.88). The TPRFA group had significantly shorter operation time and ablation time than the TPLA group (p < 0.001). Complication rates were similar in both groups (20% in TPRFA and 25% in TPLA, p = 0.740), mainly urinary retention. CONCLUSION: Both TPRFA and TPLA effectively improved lower urinary tract symptoms in BPH patients, with no significant statistical difference in therapeutic efficacy observed at 12 months post-procedure. TPRFA was associated with a shorter operation time and ablation time, which may make it a new option for BPH treatment. LEVEL OF EVIDENCE: Level 3b, Retrospective Cohort Study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaLaser TherapyCatheter AblationRadiofrequency AblationHumansMaleTreatment OutcomeAgedMiddle AgedQuality of LifePostoperative ComplicationsRetrospective StudiesOperative TimePerineum

Stichwörter der Autor:innen

Benign prostatic hyperplasiaLower urinary tract symptomsTransperineal laser ablationTransperineal radiofrequency ablation

Autor:innen und Institutionen

  • Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, 95 Yongan Road, Beijing, 100050, China.
  • Clinical Epidemiology and EBM Unit, Beijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • National Clinical Research Center for Digestive Diseases, State Key Lab of Digestive Health, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Departments of Ultrasound, Division of First Medical Center, Chinese People's Liberation Army General Hospital, 28 Fuxing Rd, Beijing, 100853, China. zhangyaner301@126.com.
  • Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, 95 Yongan Road, Beijing, 100050, China. sonoshixq@ccmu.edu.cn.

Förderung

  • the Scientific Program of Tongzhou District, Beijing
  • The General Program of the National Natural Science Foundation of China

Zitieren

APA

Han, X., Yang, P., Zhao, X., Li, R., Xiao, J., Shen, H., Zhang, Y., & Shi, X. Q. (2026). Comparison of Single Fiber Transperineal Laser Ablation and Radiofrequency Ablation in the Treatment of Benign Prostatic Hyperplasia. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-026-04490-8

Vancouver

Han X, Yang P, Zhao X, Li R, Xiao J, Shen H, et al. Comparison of Single Fiber Transperineal Laser Ablation and Radiofrequency Ablation in the Treatment of Benign Prostatic Hyperplasia. CardioVascular and Interventional Radiology. 2026. doi:10.1007/s00270-026-04490-8

BibTeX
@article{Han2026,
  author = {Han, Xiao and Yang, Peipei and Zhao, Xinyu and Li, Ran and Xiao, Jing and Shen, Hongliang and Zhang, Yan and Shi, Xian-Quan},
  title = {Comparison of Single Fiber Transperineal Laser Ablation and Radiofrequency Ablation in the Treatment of Benign Prostatic Hyperplasia},
  journal = {CardioVascular and Interventional Radiology},
  year = {2026},
  doi = {10.1007/s00270-026-04490-8}
}
Kostenlos starten →